Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 (Grb2) as Fundamental Link in Insulin ResistanceReallocates ...

Bio-path Holdings Inc. has outlined its plans to develop BP-1001-A, a drug product modification of prexigebersen.

Incretin-based therapies, such as the GLP-1 receptor agonists, have transformed the treatment of metabolic diseases such as obesity and type 2 diabetes ... with both pathways leading to weight ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...

Dysregulated metabolism of amino acids and fatty acids in the third trimester were associated with increased risk for T2D among patients with gestational diabetes. Dysregulated metabolic activity in ...